oxprenolol has been researched along with Aging in 8 studies
Oxprenolol: A beta-adrenergic antagonist used in the treatment of hypertension, angina pectoris, arrhythmias, and anxiety.
Aging: The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time.
| Excerpt | Relevance | Reference |
|---|---|---|
| " For an assessment of the effects of aging on the pharmacokinetics of oxprenolol, 2 groups of 8 healthy females, mean age 21 and 68 years, respectively, were studied." | 3.66 | Pharmacokinetics of oxprenolol in the elderly. ( Kendall, MJ, 1983) |
| "Oxprenolol was well tolerated in the elderly; it produced a low incidence of typical beta-blocker side effects even when given in a once-daily regimen." | 2.65 | Clinical responses to oxprenolol in the elderly. ( Ellis, RA, 1983) |
| "Hypertension is characterized by high levels of circulating and tissue catecholamines; atherosclerosis affects mainly the aorto-iliac tract." | 1.27 | Evidence of reduced atherosclerotic lesions in broad breasted white turkeys treated with oxprenolol. ( Angelini, A; Dal Palù, C; Mazzucato, A; Pagnan, A; Pauletto, P; Pessina, AC; Scannapieco, G; Semplicini, A; Thiene, G; Vescovo, G, 1985) |
| " It has been shown that multiple dosing does not result in oxprenolol accumulation in either group and that age has no effect on the pharmacokinetics of this drug." | 1.26 | The effect of age on the pharmacokinetics of oxprenolol. ( Kendall, MJ; Quarterman, CP, 1982) |
| "Propranolol did not cause this pressor effect in prehypertensive (seven week old) SHRs." | 1.26 | Beta-adrenergic receptor blocking drugs in spontaneous hypertension. ( Levy, JV, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ellis, RA | 1 |
| Kendall, MJ | 2 |
| Quarterman, CP | 1 |
| Levy, JV | 1 |
| Bühler, FR | 2 |
| Lütold, BE | 1 |
| Pauletto, P | 1 |
| Pessina, AC | 1 |
| Pagnan, A | 1 |
| Thiene, G | 1 |
| Semplicini, A | 1 |
| Vescovo, G | 1 |
| Mazzucato, A | 1 |
| Scannapieco, G | 1 |
| Angelini, A | 1 |
| Dal Palù, C | 1 |
| Fenyvesi, T | 1 |
| Káldor, A | 1 |
| Sebestyén, K | 1 |
1 trial available for oxprenolol and Aging
| Article | Year |
|---|---|
Clinical responses to oxprenolol in the elderly.
Topics: Aged; Aging; Clinical Trials as Topic; Drug Therapy, Combination; Drug Tolerance; Humans; Hydrochlor | 1983 |
7 other studies available for oxprenolol and Aging
| Article | Year |
|---|---|
Pharmacokinetics of oxprenolol in the elderly.
Topics: Adolescent; Adult; Aged; Aging; Female; Humans; Kinetics; Middle Aged; Oxprenolol; Time Factors | 1983 |
The effect of age on the pharmacokinetics of oxprenolol.
Topics: Aged; Aging; Female; Humans; Kinetics; Middle Aged; Oxprenolol | 1982 |
Beta-adrenergic receptor blocking drugs in spontaneous hypertension.
Topics: Adrenergic beta-Antagonists; Aging; Alprenolol; Animals; Blood Pressure; Hypertension; Male; Metopro | 1976 |
[Essential hypertension: adrenergic control system, renin-angiotensin effector axis, kidney and age].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aging; Angiotensin II; Catecholamines; Diuretics; Humans; | 1976 |
Renin and age as determinants of a predominantly betablocker-based antihypertensive drug program.
Topics: Adrenergic beta-Antagonists; Adult; Aging; Aldosterone; Angiotensin II; Antihypertensive Agents; Blo | 1976 |
Evidence of reduced atherosclerotic lesions in broad breasted white turkeys treated with oxprenolol.
Topics: Aging; Animals; Aorta, Abdominal; Arteriosclerosis; Blood Pressure; Disease Models, Animal; Heart Ra | 1985 |
Heart rate after combined vagal and sympathetic blockade with atropine and different beta-receptor blocking agents.
Topics: Adrenergic beta-Antagonists; Adult; Aging; Atropine; Dose-Response Relationship, Drug; Electrocardio | 1973 |